Karsten Boehnke
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Immune cells in cancer, Cancer Cells and Metastasis, Microtubule and mitosis dynamics
Most-Cited Works
- → Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors(2017)343 cited
- → Genomic Aberrations that Activate D-type Cyclins Are Associated with Enhanced Sensitivity to the CDK4 and CDK6 Inhibitor Abemaciclib(2017)230 cited
- → Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer(2020)210 cited
- → Preclinical characterization of abemaciclib in hormone receptor positive breast cancer(2017)194 cited
- → Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures(2016)150 cited
- → Effects of fibroblasts and microenvironment on epidermal regeneration and tissue function in long-term skin equivalents(2007)148 cited
- → Authentic fibroblast matrix in dermal equivalents normalises epidermal histogenesis and dermo-epidermal junction in organotypic co-culture(2004)128 cited
- → Epidermal Homeostasis in Long-Term Scaffold-Enforced Skin Equivalents(2006)125 cited
- → Heterogeneous pathway activation and drug response modelled in colorectal-tumor-derived 3D cultures(2019)81 cited
- → Stem cells of the human epidermis and their niche: composition and function in epidermal regeneration and carcinogenesis(2012)75 cited